Walking through the wonder years of artificial DNA : peptide nucleic acid
Peptide Nucleic Acid (PNA) serves as an artificial functional analog of DNA. Being immune to enzymatic degradation and possessing strong affinity towards DNA and RNA, it is an ideal candidate for many medical and biotechnological applications that are of antisense and antigene in nature. PNAs are anticipated to have its application in DNA and RNA detection as well as quantification, to serve as antibacterial and antiviral agents, and silencing gene for developing anticancer strategies. Although, their restricted entry in both eukaryotic and prokaryotic cells limit their applications. In addition, aggregation of PNA in storage containers reduces the quality and quantity of functional PNA that makes it inadequate for their mass production and storage. To overcome these limitations, researchers have modified PNA either by the addition of diverse functional groups at various loci on its backbone, or by synthesizing chimeras with other moieties associated with various delivery agents that aids their entry into the cell. Here, this review article summarizes few of the structural modifications that are performed with PNA, methods used to improve their cellular uptake and shedding light on the applications of PNA in various prospects in biological sciences.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Molecular biology reports - 47(2020), 10 vom: 29. Okt., Seite 8113-8131 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Patel, Rohit [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 19.05.2021 Date Revised 19.05.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s11033-020-05819-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM315615427 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM315615427 | ||
003 | DE-627 | ||
005 | 20231225155313.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11033-020-05819-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1052.xml |
035 | |a (DE-627)NLM315615427 | ||
035 | |a (NLM)32990905 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Patel, Rohit |e verfasserin |4 aut | |
245 | 1 | 0 | |a Walking through the wonder years of artificial DNA |b peptide nucleic acid |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.05.2021 | ||
500 | |a Date Revised 19.05.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Peptide Nucleic Acid (PNA) serves as an artificial functional analog of DNA. Being immune to enzymatic degradation and possessing strong affinity towards DNA and RNA, it is an ideal candidate for many medical and biotechnological applications that are of antisense and antigene in nature. PNAs are anticipated to have its application in DNA and RNA detection as well as quantification, to serve as antibacterial and antiviral agents, and silencing gene for developing anticancer strategies. Although, their restricted entry in both eukaryotic and prokaryotic cells limit their applications. In addition, aggregation of PNA in storage containers reduces the quality and quantity of functional PNA that makes it inadequate for their mass production and storage. To overcome these limitations, researchers have modified PNA either by the addition of diverse functional groups at various loci on its backbone, or by synthesizing chimeras with other moieties associated with various delivery agents that aids their entry into the cell. Here, this review article summarizes few of the structural modifications that are performed with PNA, methods used to improve their cellular uptake and shedding light on the applications of PNA in various prospects in biological sciences | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Bio-medical applications | |
650 | 4 | |a Biosensors | |
650 | 4 | |a Cell penetrating peptides | |
650 | 4 | |a Cellular delivery | |
650 | 4 | |a Peptide nucleic acid (PNA) | |
650 | 4 | |a Xeno nucleic acid (XNA) | |
650 | 7 | |a Peptide Nucleic Acids |2 NLM | |
650 | 7 | |a RNA |2 NLM | |
650 | 7 | |a 63231-63-0 |2 NLM | |
650 | 7 | |a DNA |2 NLM | |
650 | 7 | |a 9007-49-2 |2 NLM | |
700 | 1 | |a Sarma, Sameera |e verfasserin |4 aut | |
700 | 1 | |a Shukla, Arpit |e verfasserin |4 aut | |
700 | 1 | |a Parmar, Paritosh |e verfasserin |4 aut | |
700 | 1 | |a Goswami, Dweipayan |e verfasserin |4 aut | |
700 | 1 | |a Saraf, Meenu |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular biology reports |d 1973 |g 47(2020), 10 vom: 29. Okt., Seite 8113-8131 |w (DE-627)NLM000008168 |x 1573-4978 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2020 |g number:10 |g day:29 |g month:10 |g pages:8113-8131 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11033-020-05819-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 47 |j 2020 |e 10 |b 29 |c 10 |h 8113-8131 |